These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1325078)

  • 21. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.
    Cunningham AC; Hasty KA; Enghild JJ; Mast AE
    Biochem J; 2002 Oct; 367(Pt 2):451-8. PubMed ID: 12117418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1.
    Ahamed J; Belting M; Ruf W
    Blood; 2005 Mar; 105(6):2384-91. PubMed ID: 15550483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of plasma tissue factor pathway inhibitor.
    Broze GJ; Lange GW; Duffin KL; MacPhail L
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):551-9. PubMed ID: 7841311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino acid sequence and inhibitory activity of rhesus monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI.
    Kamei S; Kamikubo Y; Hamuro T; Fujimoto H; Ishihara M; Yonemura H; Miyamoto S; Funatsu A; Enjyoji K; Abumiya T
    J Biochem; 1994 Apr; 115(4):708-14. PubMed ID: 8089087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High level expression of recombinant human tissue factor in Chinese hamster ovary cells as a human thromboplastin.
    Rehemtulla A; Pepe M; Edgington TS
    Thromb Haemost; 1991 May; 65(5):521-7. PubMed ID: 1871713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant full-length tissue factor pathway inhibitor fails to bind to the cell surface: implications for catabolism in vitro and in vivo.
    Ho G; Narita M; Broze GJ; Schwartz AL
    Blood; 2000 Mar; 95(6):1973-8. PubMed ID: 10706863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant tissue factor pathway inhibitor induces apoptosis in cultured rat mesangial cells via its Kunitz-3 domain and C-terminal through inhibiting PI3-kinase/Akt pathway.
    Lin YF; Zhang N; Guo HS; Kong DS; Jiang T; Liang W; Zhao ZH; Tang QQ; Ma D
    Apoptosis; 2007 Dec; 12(12):2163-73. PubMed ID: 17885802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and fast preparation of biologically active recombinant human coagulation factor VII in CHO-K1 cells.
    Xiao W; Li CQ; Xiao XP; Lin FZ
    Genet Mol Res; 2013 Dec; 12(4):6813-24. PubMed ID: 24391029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Processing and characterization of recombinant von Willebrand factor expressed in different cell types using a vaccinia virus vector.
    Meulien P; Nishino M; Mazurier C; Dott K; Piétu G; Jorieux S; Pavirani A; Girma JP; Oufkir D; Courtney M
    Thromb Haemost; 1992 Jan; 67(1):154-60. PubMed ID: 1615470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial expression, purification, and partial characterization of amino acids 94-155 of human tissue factor pathway inhibitor (TFPI) as an inhibitor of blood coagulation factor Xa.
    Day KC; Welsch DJ
    Thromb Res; 1992 Dec; 68(4-5):369-81. PubMed ID: 1290165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous presence of tissue factor pathway inhibitor (TFPI) and low molecular weight heparin has a synergistic effect in different coagulation assays.
    Valentin S; Ostergaard P; Kristensen H; Nordfang O
    Blood Coagul Fibrinolysis; 1991 Oct; 2(5):629-35. PubMed ID: 1664252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site.
    Enjyoji K; Miyata T; Kamikubo Y; Kato H
    Biochemistry; 1995 May; 34(17):5725-35. PubMed ID: 7727433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical characterization of plasma-derived tissue factor pathway inhibitor: post-translational modification of free, full-length form with particular reference to the sugar chain.
    Mori Y; Hamuro T; Nakashima T; Hamamoto T; Natsuka S; Hase S; Iwanaga S
    J Thromb Haemost; 2009 Jan; 7(1):111-20. PubMed ID: 19017259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of factor Xa inhibition by tissue factor pathway inhibitor.
    Huang ZF; Wun TC; Broze GJ
    J Biol Chem; 1993 Dec; 268(36):26950-5. PubMed ID: 8262929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo biological activities of recombinant human erythropoietin analogues produced by CHO cells, BHK cells and C127 cells.
    Hayakawa T; Wada M; Mizuno K; Abe S; Miyashita M; Ueda M
    Biologicals; 1992 Dec; 20(4):253-7. PubMed ID: 1305401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification, molecular cloning, and expression of a novel growth-promoting factor for retinal pigment epithelial cells, REF-1/TFPI-2.
    Tanaka Y; Utsumi J; Matsui M; Sudo T; Nakamura N; Mutoh M; Kajita A; Sone S; Kigasawa K; Shibuya M; Reddy VN; Zhang Q; Iwata T
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):245-52. PubMed ID: 14691180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human recombinant tissue factor pathway inhibitor induces apoptosis in cultured human endothelial cells.
    Hamuro T; Kamikubo Y; Nakahara Y; Miyamoto S; Funatsu A
    FEBS Lett; 1998 Jan; 421(3):197-202. PubMed ID: 9468305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel degradation pathway of tissue factor pathway inhibitor: incorporation into fibrin clot and degradation by thrombin.
    Ohkura N; Enjyoji K; Kamikubo Y; Kato H
    Blood; 1997 Sep; 90(5):1883-92. PubMed ID: 9292521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model.
    Elsayed YA; Nakagawa K; Kamikubo YI; Enjyoji KI; Kato H; Sueishi K
    Am J Clin Pathol; 1996 Nov; 106(5):574-83. PubMed ID: 8929465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.